Sample Analysis Tables

Attachment 12: Sample Analysis Tables

TABLE 1. HIV infection for all participants and for participants who did not self-report a previous positive HIV test result, by selected characteristics — United States,

^{All participants*} Non-SRP participants^†

Total no. tested

HIV infection

Total no. tested

HIV infection

Characteristics No. (%) No. (%)

Gender Male Female

Race/Ethnicity

American Indian/Alaska Native Asian

Black Hispanic/Latino^¶

Native Hawaiian/Other Pacific Islander White

Age group (yrs)

18-29

30-39

40-49

50-59

≥ 60

Education

< High school

High school diploma or equivalent

> High school

Income^**

At or below federal poverty level Above federal poverty level

Health insurance

None Public only Private only

Other/multiple

Visited health-care provider, past 12 months

Yes No

Homeless, past 12 months

Yes No

Arrested, past 12 months

Yes No

Drug injected most frequently, past 12 months

Heroin alone

Heroin and cocaine^†† Cocaine or crack alone Methamphetamine Other^§§

Male-male sex (among males only)

Never

≤ 12 months before interview

> 12 before interview

Alcohol or drug treatment program^¶¶

≤ 12 months before interview

> 12 months before interview Never been in a treatment program

Self-reported previous HIV test result

Negative Positive

Never obtained result

Never tested Other^***

Time since last HIV test^†††

≤ 3 months

4-6 months

7-12 months

^{≥ 13 months Never} tested Other^§§§

Geographic region

Total

Abbreviations: HIV = human immunodeficiency virus; SRP= self-reported a previous positive HIV test result.

* Sample includes participants with a valid HIV test result who self-reported a previous positive HIV test result. Numbers may not add to totals because of missing data.

^† Sample includes participants with a valid HIV test result who did not self-report a previous positive HIV test result. Numbers may not add to totals because of missing data.

^§ Suppressed due to small cell sizes.

^¶ Persons of Hispanic/Latino ethnicity might be of any race.

** Poverty level is based on household income and household size.

^†† Injected together, or with the same frequency.

^§§ Other drugs injected alone or two or more drugs injected with the same frequency.

TABLE 2. Description of survey participants who did not self-report a previous positive HIV test result*, by gender — United States,
	Total males		Total females			Total
Characteristic	No.	(%)		No.	(%)		No.	(%)
Race/Ethnicity
American Indian/Alaska Native
Asian
Black
Hispanic/Latino¶
Native Hawaiian/Other Pacific Islander
White
Hispanic Ancestry§
Mexican
Puerto Rican
Cuban
Dominican
Other
Multiple
Age group (yrs)
18-29
30-39
40-49
50-59
≥ 60
Education
< High school
High school diploma or equivalent
> High school
Income¶
At or below federal poverty level
Above federal poverty level
Health insurance
None
Public only
Private only
Other/multiple
Visited health-care provider, past 12 months
Yes
No
Homeless, past 12 months
Yes
No
Arrested, past 12 months
Yes
No
Drug injected most frequently, past 12 months
Heroin alone
Heroin and cocaine**
Cocaine or crack alone
Methamphetamine
Other††
Alcohol or drug treatment program§§
≤ 12 months before interview
> 12 months before interview
Never been in a treatment program
Geographic region
Total
Abbreviations: HIV = human immunodeficiency virus.
* Sample excludes participants who self-reported a previous positive HIV test result. Numbers may not add to totals because of missing data. Column percentages may not add to 100 because of rounding.
† Persons of Hispanic/Latino ethnicity might be of any race.
§ Among those who reported Hispanic/Latino race/ethnicity.
¶ Poverty level is based on household income and household size.
** Injected together, or with the same frequency.
†† Other drugs injected alone or two or more drugs injected with the same frequency.
§§ Includes outpatient, residential, detox, and methadone treatment programs.

TABLE 3. Injection drug use during the past 12 months for participants who did not self-report a previous positive HIV test resul*t, by type of drug^†, frequency of injection, and selected characteristics — United States

Heroin

Speedball^§

Cocaine or crack

Methamphetamine

Other/multiple

Injected in past 12 months

Injected daily^¶

Injected in past 12 months

Injected daily^¶

Injected in past 12 months

Injected daily^¶

Injected in past 12 months

Injected daily^¶

Injected in past 12 months

Injected daily^¶

Characteristics ^{No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)} Gender

Male Female

Race/Ethnicity

American Indian/Alaska Native Asian

Black

Hispanic/Latino^¶

Native Hawaiian/Other Pacific Islander White

Age group (yrs)

18-29

30-39

40-49

50-59

≥ 60

Education

< High school

High school diploma or equivalent

> High school

income^§§

At or below federal poverty level Above federal poverty level

Arrested, past 12 months

Yes No

HIV test result Negative Positive

Geographic region

Total

Total

Abbreviations: HIV = human immunodeficiency virus;

* Sample excludes participants who self-reported a previous positive HIV test result. Numbers may not add to totals because of missing data.

^† Participants may report the use of more than one drug as categories are not mutually exclusive.

^§ Refers to heroin and cocaine being injected together as speedball.

^¶ Among those participants who injected that drug in the past 12 months.

** Suppressed because of small cell size.

^†† Persons of Hispanic/Latino ethnicity might be of any race.

^§§ Poverty level is based on household income and household size.

TABLE 4. Risky injection practices during the past 12 months for participants who did not self-report a previous positive HIV test result*, by selected characteristics — United States
Receptive sharing of syringes†		Receptive sharing of injection equipment§			Receptive sharing of syringes to divide drugs¶			Any receptive sharing**
Characteristic
No.	(%)		No.	(%)		No.	(%)		No.	(%)	Total
Gender
Male
Female
Race/Ethnicity
American Indian/Alaska Native
Asian
Black
Hispanic/Latino¶
Native Hawaiian/Other Pacific Islander
White
Age group (yrs)
18-29
30-39
40-49
50-59
≥ 60
Education
< High school
High school diploma or equivalent
> High school
income§§
At or below federal poverty level
Above federal poverty level
Homeless, past 12 months
Yes
No
Arrested, past 12 months
Yes
No
Drug injected most frequently, past 12 months
Heroin alone
Heroin and cocaine¶¶
Cocaine or crack alone
Methamphetamine
Other***
Hepatitis C testing†††
Yes
No
Hepatitis C diagnosis§§§
Yes
No
Had unprotected**** vaginal sex, past 12 months
Yes
No
Had unprotected**** anal sex, past 12 months
Yes
No
Had more than one opposite sex partner, past 12 months
Yes
No
HIV test result
Negative
Positive
Geographic Region
Total
Abbreviations: HIV = human immunodeficiency virus.
* Sample excludes participants who self-reported a previous positive HIV test result. Numbers may not add to totals because of missing data.
† During the past 12 months, used needles that was already been used by someone else.
§ During the past 12 months, used cooker (spoon, bottle cap, etc) or cotton (used to filter particles from drug solution) that was already used by someone else or shared water for rinising needles or preparing drugs.
¶ During the past 12 months, divided drug solution with a syringe someone already injected with.
** During the past 12 months, used needles that was already been used by someone else, used cooker or cotton that was already used by someone else or shared water for rinsing needles or preparing drugs, or divided drug solution with a syringe someone already injected with.
†† Persons of Hispanic/Latino ethnicity might be of any race.
§§ Poverty level is based on household income and household size.
¶¶ Injected together, or with the same frequency.
*** Other drugs injected alone or two or more drugs injected with the same frequency.
††† Self-reported had ever been told had hepatitis C by a health care provider or ever had a blood test to check for hepatitis C infection.
§§§ Self-reported had ever been told had hepatitis C by a health care provider.